ROCK HILL, SC, Aug. 18, 2022 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced the appointments of Dr. Toby Cosgrove, former President and CEO of The Cleveland Clinic, and Dr. Bon Ku , director of the Health Design Lab at Thomas Jefferson University, as the fourth and fifth members of the company’s newly created Medical Advisory Board (MAB). Dr. Cosgrove and Dr. Ku will join former Secretary of Health and Human Services Alex Azar, Dr. Stephen K. Klasko and former US Secretary of Veterans Affairs David J. Shulkin as members of the advisory board. The primary mission of the Board of Directors is to provide strategic insight, advice and recommendations for the company’s growing efforts in the field of regenerative medicine.
Dr. Cosgrove has distinguished himself as a leader of one of the world’s most recognized healthcare institutions, as a renowned physician, and as a forward-looking innovator in healthcare . Affiliated with the Cleveland Clinic Health System for nearly 50 years, Dr. Cosgrove served as President and CEO from 2004 to 2017 and is currently the Clinic’s Executive Advisor. As President and CEO, Dr. Cosgrove oversaw a $6 billion annual revenue institution comprised of the Cleveland Clinic, more than 20 Ohio-based hospitals, family health centers and surgical facilities, as well as Cleveland Clinic affiliates in other U.S. states and internationally. During Dr. Cosgrove’s tenure as head of the Cleveland Clinic, it was ranked among the top three hospitals in America by US News and World Report, and he championed a wide range of initiatives to improve outcomes clinics, increase patient satisfaction and focus the clinic’s delivery of health care services around specific organ systems and diseases.
Prior to serving as the Cleveland Clinic’s senior executive, Dr. Cosgrove was a cardiac surgeon at the clinic and served as chairman of its department of thoracic and cardiovascular surgery from 1989 to 2004. He performed more than 22,000 surgeries at the course of his career. and is widely considered a pioneer in the field of advanced surgical techniques. Deeply committed to medical innovation and the application of new technologies to benefit patients, Dr. Cosgrove has filed over 30 patents for new medical and clinical products used in surgical environments.
Dr. Bon Ku has had a distinguished career both as a practicing medical clinician and as a visionary advocate for using technological innovations to solve pressing health issues. Dr. Ku is the Marta and Robert Adelson Professor of Medicine and Design at Thomas Jefferson University as well as an emergency physician at the University’s Sidney Kimmel Medical College.
Dr. Ku is widely considered an authority on accelerating healthcare innovation through the use of modern technology tools such as virtualization, digital modeling, prototyping and additive manufacturing . He is co-founder and director of the Health Design Lab at Thomas Jefferson University, a unique institution that works with medical students, researchers, and physicians to develop new medical devices and innovative design concepts for the healthcare industry. health. The Health Design Lab led by Dr. Ku includes a clinical 3D printing and bioprinting lab and is home to the JeffSolves MedTech initiative, which serves as a center for incubating and commercializing new medical technologies. Dr. Ku has also authored numerous peer-reviewed publications on the application of 3D printed medical devices and digital models to improve surgical outcomes, optimize treatments, and advance personalized medicine.
Commenting on the appointments of Drs. Cosgrove and Ku, President and CEO of 3D Systems, Dr. Jeffrey Graves, said, “We are extremely pleased to welcome Dr. Cosgrove and Dr. Ku to our Medical Advisory Board. Both of these professionals have impeccable track records in combining hands-on experience in medical practice with a clear passion for using innovative approaches and modern technology to transform healthcare outcomes. Both Dr. Cosgrove and Dr. Ku will be in a unique position to advise 3D Systems as we build a world-class regenerative medicine business and pursue 3D printing-based advancements in areas such as accelerated pharmaceutical development, printing of human tissues and organs, medical device innovation. , and personalized medicine.
Forward-looking statements
Certain statements made in this release that are not statements of historical or current fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors. that may cause the actual results, performance or achievements of the company to differ materially from historical results or any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by words such as “believes”, “believes”, “expects”, “may”, “will”, “estimates”, “intends”. , “anticipate” or “plan” or the negative of these terms or other comparable terms. Forward-looking statements are based on management’s current beliefs, assumptions and expectations and may include comments about the company’s beliefs and expectations regarding future events and trends affecting its business and are necessarily subject to uncertainties, including many are beyond the company’s control. The factors described under the headings “Forward-Looking Statements” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or anticipated in the forward-looking statements. research statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, the forward-looking statements are not and should not be taken as guarantees of future performance or results, and they will not necessarily prove to be precise indications. the times at which these performances or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems undertakes no obligation to update or revise any forward-looking statements made by or on behalf of management, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law. requires it.
About 3D Systems
Over 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance and reliability to every interaction – enabling our customers to create products and business models never before possible. Through our unique offering of hardware, software, materials and services, each application-specific solution is powered by the expertise of our application engineers who work with customers to transform the way they deliver their products and services. 3D Systems’ solutions serve a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace and defense, automotive, and durable goods. More information about the company is available at www.3dsystems.com.
Contact with investors: investor.relations@3dsystems.com
Media contact: press@3dsystems.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2b14f06b-98f9-4c66-8c02-b57375cab66d
